Ameriprise’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Buy |
44,946
+3,923
| +10% | +$26.4K | ﹤0.01% | 3664 |
|
|
2025
Q1 | $371K | Buy |
41,023
+399
| +1% | +$3.61K | ﹤0.01% | 3574 |
|
|
2024
Q4 | $702K | Buy |
40,624
+2,517
| +7% | +$43.5K | ﹤0.01% | 3374 |
|
|
2024
Q3 | $609K | Buy |
38,107
+24,560
| +181% | +$392K | ﹤0.01% | 3407 |
|
|
2024
Q2 | $193K | Buy |
+13,547
| New | +$193K | ﹤0.01% | 3697 |
|